Polar Capital Holdings’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $79M | Buy |
1,250,870
+750,870
| +150% | +$47.4M | 0.41% | 66 |
|
2025
Q1 | $26.5M | Sell |
500,000
-1,000,000
| -67% | -$53M | 0.16% | 129 |
|
2024
Q4 | $84M | Hold |
1,500,000
| – | – | 0.47% | 59 |
|
2024
Q3 | $78.6M | Hold |
1,500,000
| – | – | 0.37% | 60 |
|
2024
Q2 | $61.6M | Hold |
1,500,000
| – | – | 0.36% | 73 |
|
2024
Q1 | $65M | Sell |
1,500,000
-250,000
| -14% | -$10.8M | 0.34% | 72 |
|
2023
Q4 | $80.4M | Sell |
1,750,000
-750,000
| -30% | -$34.5M | 0.49% | 55 |
|
2023
Q3 | $57.3M | Buy |
2,500,000
+250,000
| +11% | +$5.73M | 0.42% | 69 |
|
2023
Q2 | $37.1M | Buy |
2,250,000
+500,000
| +29% | +$8.25M | 0.19% | 100 |
|
2023
Q1 | $31.2M | Buy |
1,750,000
+500,000
| +40% | +$8.92M | 0.2% | 111 |
|
2022
Q4 | $36.4M | Buy |
1,250,000
+535,261
| +75% | +$15.6M | 0.29% | 104 |
|
2022
Q3 | $17.5K | Buy |
+714,739
| New | +$17.5K | 0.11% | 154 |
|